These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 18298700

  • 21. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S.
    Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
    [Abstract] [Full Text] [Related]

  • 22. Topiramate for migraine prophylaxis in pediatric patients.
    Deaton TL, Mauro LS.
    Ann Pharmacother; 2014 May; 48(5):638-43. PubMed ID: 24566461
    [Abstract] [Full Text] [Related]

  • 23. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study.
    Lewis D, Paradiso E.
    Headache; 2007 May; 47(10):1409-17. PubMed ID: 18052950
    [Abstract] [Full Text] [Related]

  • 24. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
    Wilding J, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M, OBES-002 Study Group.
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1399-410. PubMed ID: 15486569
    [Abstract] [Full Text] [Related]

  • 25. Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.
    Bussone G, Usai S, D'Amico D.
    Neurol Sci; 2006 May; 27 Suppl 2():S159-63. PubMed ID: 16688622
    [Abstract] [Full Text] [Related]

  • 26. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J.
    Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
    [Abstract] [Full Text] [Related]

  • 27. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial.
    Lakshmi CV, Singhi P, Malhi P, Ray M.
    J Child Neurol; 2007 Jul; 22(7):829-35. PubMed ID: 17715274
    [Abstract] [Full Text] [Related]

  • 28. Antiepileptic drugs in migraine prevention.
    Mathew NT.
    Headache; 2001 Jul; 41 Suppl 1():S18-24. PubMed ID: 11903536
    [Abstract] [Full Text] [Related]

  • 29. Topiramate improves health-related quality of life when used to prevent migraine.
    Diamond M, Dahlöf C, Papadopoulos G, Neto W, Wu SC.
    Headache; 2005 Sep; 45(8):1023-30. PubMed ID: 16109116
    [Abstract] [Full Text] [Related]

  • 30. Topiramate: new indication. Migraine prevention: best avoided.
    Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
    [Abstract] [Full Text] [Related]

  • 31. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [Abstract] [Full Text] [Related]

  • 32. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D, Ferraro D, Zelano G, Capuano A, Vollono C, Gabriele C, Di Trapani G.
    Clin Neuropharmacol; 2006 Jan; 29(5):269-75. PubMed ID: 16960472
    [Abstract] [Full Text] [Related]

  • 33. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
    Mathew NT, Jaffri SF.
    Headache; 2009 Jan; 49(10):1466-78. PubMed ID: 19912346
    [Abstract] [Full Text] [Related]

  • 34. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J.
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [Abstract] [Full Text] [Related]

  • 35. Topiramate in Migraine Prevention: A 2016 Perspective.
    Silberstein SD.
    Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
    [Abstract] [Full Text] [Related]

  • 36. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.
    Mei D, Capuano A, Vollono C, Evangelista M, Ferraro D, Tonali P, Di Trapani G.
    Neurol Sci; 2004 Dec; 25(5):245-50. PubMed ID: 15624081
    [Abstract] [Full Text] [Related]

  • 37. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
    MacGregor EA, Pawsey SP, Campbell JC, Hu X.
    Gend Med; 2010 Apr; 7(2):88-108. PubMed ID: 20435272
    [Abstract] [Full Text] [Related]

  • 38. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW, Silberstein S, Saper J, Freitag FG, Cady RK, Rapoport AM, Mathew NT, Hulihan J, Crivera C, Rupnow MF, Mao L, Finlayson G, Greenberg SJ.
    Headache; 2007 Apr; 47(10):1398-408. PubMed ID: 18052949
    [Abstract] [Full Text] [Related]

  • 39. Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting.
    Malessa R, Gendolla A, Steinberg B, Schmitt L, Bornhoevd K, Djelani M, Schäuble B, TOPMAT-MIG-3004 investigators.
    Curr Med Res Opin; 2010 May; 26(5):1119-29. PubMed ID: 20225996
    [Abstract] [Full Text] [Related]

  • 40. Topiramate in the prophylactic treatment of migraine in children.
    Campistol J, Campos J, Casas C, Herranz JL.
    J Child Neurol; 2005 Mar; 20(3):251-3. PubMed ID: 15832623
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.